Seeger Weiss Attorneys Publish Article on Whistleblower Protections in Trial Magazine

Seeger Weiss attorneys Stephen A. Weiss and Justin M. Smigelsky have published an article titled “Sounding the Alarm” in the July 2025 issue of Trial Magazine, the publication of the American Association for Justice.

July 2, 2025

SW44567

Seeger Weiss attorneys Stephen A. Weiss and Justin M. Smigelsky have published an article titled “Sounding the Alarm” in the July 2025 issue of Trial Magazine, the publication of the American Association for Justice.

The article examines strategies for protecting whistleblowers in False Claims Act cases, drawing from their representation in United States v. Stimwave Technologies, Inc. The case involved a medical device company that fraudulently directed its staff to offer a dummy plastic component with no functionality to qualify for higher Medicare reimbursement rates.

After one of Stimwave’s sales representatives served as a whistleblower, the government secured significant results: a halt in the manufacture and distribution of the adulterated medical device, the company’s admission of wrongdoing, a federally monitored corporate compliance program, $10 million in monetary penalties, and the prosecution and conviction of the company’s CEO.

The piece details practical strategies for shielding whistleblower identities and discusses essential pre-filing considerations, such as determining whether the relator possesses specific knowledge of alleged fraud, confirming original source status, navigating the “first to file” rule, and more.

As Weiss and Smigelsky describe, “Whistleblowers worry about the impact their reporting will have on their professional and personal lives.”

Read this important piece in the July issues of Trial Magazine here: https://www.justice.org/resources/publications/trial-magazine

Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More